micdotcom:
Remember Martin Shkreli? He’s the dude that raised the cost of infection-fighting drug Daraprim from $13.50 per tablet to $750.
Well now, Imprimis Pharmaceuticals Inc. has announced they’ll sell a Daraprim competitor containing the same active ingredients for just $1 a pill.
Not only that, but they’re looking at “many more” cases of price jacking as potential competitors. Despite the low price, it’s actually smart business.